Indicated for: psoriasis
Route of administration: cutaneous
Substance: calcipotriol + betamethasone (immunomodulator + glucocorticoid)
ATC: D05AX52 (Dermatologicals | Antipsoriatics for topical use | Other antipsoriatics for topical use)
Calcipotriol and betamethasone are used together for the treatment of plaque psoriasis, a chronic skin condition characterized by red patches covered with whitish scales. This combination reduces inflammation, itching, and slows down the excessive growth of skin cells.
Calcipotriol is a vitamin D analog that helps normalize the cell regeneration process, while betamethasone is a potent corticosteroid that reduces inflammation and suppresses local immune reactions.
The treatment is applied topically, usually in the form of an ointment or gel, and is intended for short-term use to avoid corticosteroid-related side effects. It is important to avoid application on the face, skin folds, or areas with thin skin.
Side effects may include local irritation, burning sensation, or itching. Long-term use can lead to skin thinning or other corticosteroid-related complications.